According to research from Qualtrics, 30% of consumers started purchasing from new brands during the past 18 months because they liked new safety measures adopted and 22% stopped shopping with a brand because they felt the health and safety measures were insufficient.
The acquisition marks Hikma’s expansion into Canada and includes a portfolio of 25 sterile injectable products, three in-licensed ophthalmic products and a pipeline of seven additional products.
One hundred percent of donations collected from Feb. 2 to 15 will be used to support the Urban League of Metropolitan St. Louis’ Save Our Sons program, the company said.
